First Lady Sajidha Mohamed stated on Wednesday that her main focus is to guarantee continuous access to high-quality medications.

She delivered the statements during her trip to the Drug Regulatory Authority of Pakistan (DRAP) in Islamabad, where she spoke to senior officials and personnel as part of her current visit to Pakistan.

She emphasized that ensuring ongoing access to safe, quality-assured medicines is a primary national duty for an island nation like the Maldives, where communities are spread across various locations. She emphasized that maintaining public trust in medications relies on stringent scientific standards, effective regulatory bodies, and positive international collaboration.

Emphasizing the enduring bilateral ties between the Maldives and Pakistan, the First Lady expressed gratitude to Pakistan for its assistance to the Maldivian health sector, which includes sending Pakistani medical professionals and training Maldivian doctors, nurses, and health workers. She additionally characterized the Memorandum of Understanding on Health Cooperation as a significant advancement, emphasizing that the framework will promote technical exchange, enhance capacity building, and enable the sharing of regulatory best practices.

She mentioned that the genuine worth of the partnership will be evident in more robust health systems and beneficial transformations in individuals' lives. In closing her statements, the First Lady expressed gratitude to the Government and citizens of Pakistan. The President’s Office noted that she also conveyed gratitude for the work of DRAP officials and staff in protecting public health and expressed optimism for enhanced bilateral collaboration.

Prior to her visit to DRAP, the First Lady explored the National Institute of Health in Islamabad.